{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:32:33Z","timestamp":1793658753381,"version":"4.5.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"DOI":"10.1038\/s41423-024-01228-9","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T06:03:20Z","timestamp":1730181800000},"page":"1491-1504","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Specific ECM degradation potentiates the antitumor activity of CAR-T cells in solid tumors"],"prefix":"10.1038","volume":"21","author":[{"given":"Rui","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruotong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shukun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8854-4672","authenticated-orcid":false,"given":"Angang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6693-1113","authenticated-orcid":false,"given":"Bo","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,29]]},"reference":[{"key":"1228_CR1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41571-019-0297-y","volume":"17","author":"S Rafiq","year":"2020","unstructured":"Rafiq S, Hackett CS, Brentjens RJ. Engineering strategies to overcome the current roadblocks in CAR T cell therapy. Nat Rev Clin Oncol. 2020;17:147\u201367.","journal-title":"Nat Rev Clin Oncol"},{"key":"1228_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s43018-022-00347-4","volume":"3","author":"MV Maus","year":"2022","unstructured":"Maus MV. A decade of CAR T-cell evolution. Nat Cancer. 2022;3:270\u20131.","journal-title":"Nat Cancer"},{"key":"1228_CR3","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nbt.4086","volume":"36","author":"K Adachi","year":"2018","unstructured":"Adachi K, Kano Y, Nagai T, Okuyama N, Sakoda Y, Tamada K. IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T-cell survival in the tumor. Nat Biotechnol. 2018;36:346\u201351.","journal-title":"Nat Biotechnol"},{"key":"1228_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-020-00890-6","volume":"13","author":"Y Tian","year":"2020","unstructured":"Tian Y, Li Y, Shao Y, Zhang Y. Gene modification strategies for next-generation CAR T cells against solid cancers. J Hematol Oncol. 2020;13:54.","journal-title":"J Hematol Oncol"},{"key":"1228_CR5","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s11427-019-9665-8","volume":"63","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, Xiao X, Saw PE, Wu W, Huang H, Chen J, et al. Chimeric antigen receptor T cells in solid tumors: a war against the tumor microenvironment. Sci China Life Sci. 2020;63:180\u2013205.","journal-title":"Sci China Life Sci"},{"key":"1228_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41392-021-00544-0","volume":"6","author":"J Huang","year":"2021","unstructured":"Huang J, Zhang L, Wan D, Zhou L, Zheng S, Lin S, et al. Extracellular matrix and its therapeutic potential for cancer treatment. Signal Transduct Target Ther. 2021;6:153.","journal-title":"Signal Transduct Target Ther"},{"key":"1228_CR7","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.cell.2017.01.016","volume":"168","author":"WA Lim","year":"2017","unstructured":"Lim WA, June CH. The principles of engineering immune cells to treat cancer. Cell. 2017;168:724\u201340.","journal-title":"Cell"},{"key":"1228_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00459-7","volume":"11","author":"RC Sterner","year":"2021","unstructured":"Sterner RC, Sterner RM. CAR-T-cell therapy: current limitations and potential strategies. Blood Cancer J. 2021;11:69.","journal-title":"Blood Cancer J"},{"key":"1228_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01670-1","volume":"21","author":"M Xu","year":"2022","unstructured":"Xu M, Zhang T, Xia R, Wei Y, Wei X. Targeting the tumor stroma for cancer therapy. Mol Cancer. 2022;21:208.","journal-title":"Mol Cancer"},{"key":"1228_CR10","doi-asserted-by":"crossref","unstructured":"Gordon-Weeks A, Yuzhalin AE. Cancer Extracellular Matrix Proteins Regulate Tumour Immunity. Cancers (Basel). 2020;12:3331.","DOI":"10.3390\/cancers12113331"},{"key":"1228_CR11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1042\/CS20210679","volume":"136","author":"N Kolesnikoff","year":"2022","unstructured":"Kolesnikoff N, Chen CH, Samuel MS. Interrelationships between the extracellular matrix and the immune microenvironment that govern epithelial tumor progression. Clin Sci (Lond). 2022;136:361\u201377.","journal-title":"Clin Sci (Lond)"},{"key":"1228_CR12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40425-019-0556-6","volume":"7","author":"DE Kuczek","year":"2019","unstructured":"Kuczek DE, Larsen A, Thorseth ML, Carretta M, Kalvisa A, Siersb\u00e6k MS, et al. Collagen density regulates the activity of tumor-infiltrating T cells. J Immunother Cancer. 2019;7:68.","journal-title":"J Immunother Cancer"},{"key":"1228_CR13","doi-asserted-by":"crossref","unstructured":"Nicolas-Boluda A, Vaquero J, Vimeux L, Guilbert T, Barrin S, Kantari-Mimoun C, et al. Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment. Elife. 2021;10:e58688.","DOI":"10.7554\/eLife.58688"},{"key":"1228_CR14","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1158\/2326-6066.CIR-13-0027","volume":"2","author":"LC Wang","year":"2014","unstructured":"Wang LC, Lo A, Scholler J, Sun J, Majumdar RS, Kapoor V, et al. Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity. Cancer Immunol Res. 2014;2:154\u201366.","journal-title":"Cancer Immunol Res"},{"key":"1228_CR15","doi-asserted-by":"publisher","first-page":"5330","DOI":"10.1158\/1078-0432.CCR-22-1379","volume":"28","author":"IK Lee","year":"2022","unstructured":"Lee IK, Noguera-Ortega E, Xiao Z, Todd L, Scholler J, Song D, et al. Monitoring therapeutic response to Anti-FAP CAR T cells using [18F]AlF-FAPI-74. Clin Cancer Res. 2022;28:5330\u201342.","journal-title":"Clin Cancer Res"},{"key":"1228_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04080-z","volume":"21","author":"Y Liu","year":"2023","unstructured":"Liu Y, Sun Y, Wang P, Li S, Dong Y, Zhou M, et al. FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer. J Transl Med. 2023;21:255.","journal-title":"J Transl Med"},{"key":"1228_CR17","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1084\/jem.20130110","volume":"210","author":"E Tran","year":"2013","unstructured":"Tran E, Chinnasamy D, Yu Z, Morgan RA, Lee CC, Restifo NP, et al. Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia. J Exp Med. 2013;210:1125\u201335.","journal-title":"J Exp Med"},{"key":"1228_CR18","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nm.3833","volume":"21","author":"I Caruana","year":"2015","unstructured":"Caruana I, Savoldo B, Hoyos V, Weber G, Liu H, Kim ES, et al. Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes. Nat Med. 2015;21:524\u20139.","journal-title":"Nat Med"},{"key":"1228_CR19","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1200\/JCO.18.01295","volume":"37","author":"RK Ramanathan","year":"2019","unstructured":"Ramanathan RK, McDonough SL, Philip PA, Hingorani SR, Lacy J, Kortmansky JS, et al. Phase IB\/II randomized study of FOLFIRINOX plus pegylated recombinant human hyaluronidase versus FOLFIRINOX alone in patients with metastatic pancreatic adenocarcinoma: SWOG S1313. J Clin Oncol. 2019;37:1062\u20139.","journal-title":"J Clin Oncol"},{"key":"1228_CR20","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2016.01.012","volume":"164","author":"L Morsut","year":"2016","unstructured":"Morsut L, Roybal KT, Xiong X, Gordley RM, Coyle SM, Thomson M, et al. Engineering customized cell sensing and response behaviors using synthetic notch receptors. Cell. 2016;164:780\u201391.","journal-title":"Cell"},{"key":"1228_CR21","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cell.2016.09.011","volume":"167","author":"KT Roybal","year":"2016","unstructured":"Roybal KT, Williams JZ, Morsut L, Rupp LJ, Kolinko I, Choe JH, et al. Engineering T cells with customized therapeutic response programs using synthetic notch receptors. Cell. 2016;167:419\u201332.e416.","journal-title":"Cell"},{"key":"1228_CR22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ymthe.2022.08.021","volume":"31","author":"G Wang","year":"2023","unstructured":"Wang G, Zhang Z, Zhong K, Wang Z, Yang N, Tang X, et al. CXCL11-armed oncolytic adenoviruses enhance CAR-T-cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma. Mol Ther. 2023;31:134\u201353.","journal-title":"Mol Ther"},{"key":"1228_CR23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molmed.2017.02.007","volume":"23","author":"D Dutta","year":"2017","unstructured":"Dutta D, Heo I, Clevers H. Disease modeling in stem cell-derived 3D organoid systems. Trends Mol Med. 2017;23:393\u2013410.","journal-title":"Trends Mol Med"},{"key":"1228_CR24","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41573-021-00189-2","volume":"20","author":"AJ Hou","year":"2021","unstructured":"Hou AJ, Chen LC, Chen YY. Navigating CAR-T cells through the solid-tumor microenvironment. Nat Rev Drug Discov. 2021;20:531\u201350.","journal-title":"Nat Rev Drug Discov"},{"key":"1228_CR25","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ccr.2012.01.007","volume":"21","author":"PP Provenzano","year":"2012","unstructured":"Provenzano PP, Cuevas C, Chang AE, Goel VK, Von Hoff DD, Hingorani SR. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell. 2012;21:418\u201329.","journal-title":"Cancer Cell"},{"key":"1228_CR26","doi-asserted-by":"publisher","first-page":"188435","DOI":"10.1016\/j.bbcan.2020.188435","volume":"1874","author":"B Wen","year":"2020","unstructured":"Wen B, Xu LY, Li EM. LOXL2 in cancer: regulation, downstream effectors and novel roles. Biochim Biophys Acta Rev Cancer. 2020;1874:188435.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1228_CR27","doi-asserted-by":"crossref","unstructured":"Lampi MC, Reinhart-King CA. Targeting extracellular matrix stiffness to attenuate disease: From molecular mechanisms to clinical trials. Sci Transl Med. 2018;10:eaao0475.","DOI":"10.1126\/scitranslmed.aao0475"},{"key":"1228_CR28","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1146\/annurev.cellbio.17.1.463","volume":"17","author":"MD Sternlicht","year":"2001","unstructured":"Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 2001;17:463\u2013516.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"1228_CR29","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.semcancer.2010.05.002","volume":"20","author":"D Bourboulia","year":"2010","unstructured":"Bourboulia D, Stetler-Stevenson WG. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Semin Cancer Biol. 2010;20:161\u20138.","journal-title":"Semin Cancer Biol"},{"key":"1228_CR30","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/s41416-019-0578-3","volume":"121","author":"W Zhang","year":"2019","unstructured":"Zhang W, Liu L, Su H, Liu Q, Shen J, Dai H, et al. Chimeric antigen receptor macrophage therapy for breast tumors mediated by targeting the tumor extracellular matrix. Br J Cancer. 2019;121:837\u201345.","journal-title":"Br J Cancer"},{"key":"1228_CR31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s13046-022-02479-y","volume":"41","author":"C Chiriaco","year":"2022","unstructured":"Chiriaco C, Donini C, Cortese M, Ughetto S, Modica C, Martinelli I, et al. Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy. J Exp Clin Cancer Res. 2022;41:309.","journal-title":"J Exp Clin Cancer Res"},{"key":"1228_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.958960","volume":"13","author":"J Hu","year":"2022","unstructured":"Hu J, Wang Z, Liao C, Chen Z, Kang F, Lin C, et al. Induced expression of CCL19 promotes the anti-tumor ability of CAR-T cells by increasing their infiltration ability. Front Immunol. 2022;13:958960.","journal-title":"Front Immunol"},{"key":"1228_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18298-8","volume":"11","author":"DH Peng","year":"2020","unstructured":"Peng DH, Rodriguez BL, Diao L, Chen L, Wang J, Byers LA, et al. Collagen promotes anti-PD-1\/PD-L1 resistance in cancer through LAIR1-dependent CD8(+) T-cell exhaustion. Nat Commun. 2020;11:4520.","journal-title":"Nat Commun"},{"key":"1228_CR34","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nm.3838","volume":"21","author":"AH Long","year":"2015","unstructured":"Long AH, Haso WM, Shern JF, Wanhainen KM, Murgai M, Ingaramo M, et al. 4-1BB costimulation ameliorates T-cell exhaustion induced by tonic signaling of chimeric antigen receptors. Nat Med. 2015;21:581\u201390.","journal-title":"Nat Med"},{"key":"1228_CR35","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1080\/14712598.2020.1738378","volume":"20","author":"S Ramakrishna","year":"2020","unstructured":"Ramakrishna S, Barsan V, Mackall C. Prospects and challenges for use of CAR T-cell therapies in solid tumors. Expert Opin Biol Ther. 2020;20:503\u201316.","journal-title":"Expert Opin Biol Ther"},{"key":"1228_CR36","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","volume":"368","author":"SA Grupp","year":"2013","unstructured":"Grupp SA, Kalos M, Barrett D, Aplenc R, Porter DL, Rheingold SR, et al. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N. Engl J Med. 2013;368:1509\u201318.","journal-title":"N. Engl J Med"},{"key":"1228_CR37","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","volume":"16","author":"Y Togashi","year":"2019","unstructured":"Togashi Y, Shitara K, Nishikawa H. Regulatory T cells in cancer immunosuppression - implications for anticancer therapy. Nat Rev Clin Oncol. 2019;16:356\u201371.","journal-title":"Nat Rev Clin Oncol"},{"key":"1228_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.734593","volume":"11","author":"G Li","year":"2021","unstructured":"Li G, Zhang Q, Han Z, Zhu Y, Shen H, Liu Z, et al. IL-7 and CCR2b co-expression-mediated enhanced CAR-T survival and infiltration in solid tumors. Front Oncol. 2021;11:734593.","journal-title":"Front Oncol"},{"key":"1228_CR39","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41586-023-05778-2","volume":"615","author":"AM Tousley","year":"2023","unstructured":"Tousley AM, Rotiroti MC, Labanieh L, Rysavy LW, Kim WJ, Lareau C, et al. Co-opting signaling molecules enables logic-gated control of CAR T cells. Nature. 2023;615:507\u201316.","journal-title":"Nature"},{"key":"1228_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1141","volume":"12","author":"L Liu","year":"2022","unstructured":"Liu L, Qu Y, Cheng L, Yoon CW, He P, Monther A, et al. Engineering chimeric antigen receptor T cells for solid tumor therapy. Clin Transl Med. 2022;12:e1141.","journal-title":"Clin Transl Med"},{"key":"1228_CR41","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.1182\/blood-2014-01-552174","volume":"123","author":"Y Xu","year":"2014","unstructured":"Xu Y, Zhang M, Ramos CA, Durett A, Liu E, Dakhova O, et al. Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15. Blood. 2014;123:3750\u20139.","journal-title":"Blood"},{"key":"1228_CR42","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.jcyt.2022.02.006","volume":"24","author":"NT Schomer","year":"2022","unstructured":"Schomer NT, Jiang ZK, Lloyd MI, Klingemann H, Boissel L. CCR7 expression in CD19 chimeric antigen receptor-engineered natural killer cells improves migration toward CCL19-expressing lymphoma cells and increases tumor control in mice with human lymphoma. Cytotherapy. 2022;24:827\u201334.","journal-title":"Cytotherapy"},{"key":"1228_CR43","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/44385","volume":"401","author":"F Sallusto","year":"1999","unstructured":"Sallusto F, Lenig D, F\u00f6rster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401:708\u201312.","journal-title":"Nature"},{"key":"1228_CR44","doi-asserted-by":"publisher","first-page":"907","DOI":"10.4049\/jimmunol.2300049","volume":"211","author":"S Mittra","year":"2023","unstructured":"Mittra S, Harding SM, Kaech SM. Memory T cells in the immunoprevention of cancer: a switch from therapeutic to prophylactic approaches. J Immunol. 2023;211:907\u201316.","journal-title":"J Immunol"},{"key":"1228_CR45","doi-asserted-by":"publisher","first-page":"ra31","DOI":"10.1126\/scisignal.2002764","volume":"5","author":"M Matsuda","year":"2012","unstructured":"Matsuda M, Koga M, Nishida E, Ebisuya M. Synthetic signal propagation through direct cell\u2012cell interaction. Sci Signal. 2012;5:ra31.","journal-title":"Sci Signal"},{"key":"1228_CR46","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/hum.2018.119","volume":"30","author":"Y Xu","year":"2019","unstructured":"Xu Y, Li S, Wang Y, Liu J, Mao X, Xing H, et al. Induced CD20 expression on B-cell malignant cells heightened the cytotoxic activity of chimeric antigen receptor engineered T cells. Hum Gene Ther. 2019;30:497\u2013510.","journal-title":"Hum Gene Ther"},{"key":"1228_CR47","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1089\/hum.2017.241","volume":"29","author":"S Li","year":"2018","unstructured":"Li S, Tao Z, Xu Y, Liu J, An N, Wang Y, et al. CD33-specific chimeric antigen receptor T cells with different co-stimulators showed potent anti-leukemia efficacy and different phenotype. Hum Gene Ther. 2018;29:626\u201339.","journal-title":"Hum Gene Ther"},{"key":"1228_CR48","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s41591-019-0422-6","volume":"25","author":"O Kopper","year":"2019","unstructured":"Kopper O, de Witte CJ, L\u00f5hmussaar K, Valle-Inclan JE, Hami N, Kester L, et al. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity. Nat Med. 2019;25:838\u201349.","journal-title":"Nat Med"},{"key":"1228_CR49","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.stemcr.2020.03.004","volume":"14","author":"N Maenhoudt","year":"2020","unstructured":"Maenhoudt N, Defraye C, Boretto M, Jan Z, Heremans R, Boeckx B, et al. Developing organoids from ovarian cancer as experimental and preclinical models. Stem Cell Rep. 2020;14:717\u201329.","journal-title":"Stem Cell Rep"}],"container-title":["Cellular & Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-024-01228-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-024-01228-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-024-01228-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T19:04:31Z","timestamp":1732907071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-024-01228-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,29]]},"references-count":49,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1228"],"URL":"https:\/\/doi.org\/10.1038\/s41423-024-01228-9","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,29]]},"assertion":[{"value":"22 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}